Nelediaden (Atorvastatin)

Atorvastatin inhibits the enzyme HMG‑CoA reductase, which is essential for cholesterol synthesis in the liver. By blocking this step, the drug reduces hepatic cholesterol production, leading to an increase in LDL‑receptor expression and enhanced removal of LDL‑cholesterol from the bloodstream.

The appropriate dose of Nelediaden is individualized by the prescribing clinician based on the patient’s baseline lipid profile, cardiovascular risk factors, age, renal and hepatic function, and response to therapy. No fixed dosing regimen is provided here.

The safety of atorvastatin during pregnancy and lactation has not been established. It is generally advised to discontinue the medication if pregnancy is confirmed, and it should be used only if the potential benefit justifies the potential risk to the fetus or infant.

To place an order, submit an enquiry on the Nelediaden product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nelediaden (atorvastatin) is a high‑potency statin with a long half‑life, allowing once‑daily dosing and effective LDL‑cholesterol reduction. Compared with lower‑potency statins, it often achieves greater lipid lowering at comparable doses, but the choice of statin depends on individual patient factors, tolerability, drug‑interaction profile and clinician preference.

Nelediaden tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Nelediaden is taken orally, usually once daily, with or without food, as directed by the prescribing healthcare professional. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

The most serious adverse effects include rhabdomyolysis (a severe form of muscle breakdown that can lead to kidney failure), significant elevations in liver enzymes indicating hepatic injury, and rare severe allergic reactions such as anaphylaxis. Patients should report unexplained muscle pain, weakness, dark urine, or signs of liver dysfunction promptly.

Nelediaden is contraindicated in patients with known hypersensitivity to atorvastatin or any component of the formulation, active liver disease, and in women who are pregnant or may become pregnant. Caution is also advised for individuals with severe renal impairment or those taking contraindicated medications.